Third-party logistics providers (3PLs) play a critical role in the pharma supply chain, being tasked with the management of ...
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies ...
Liminatus Pharma, Inc., a preclinical-stage biopharmaceutical company focused on cancer immunotherapies, has announced the initiation of a strategic review to consider the potential use of regulated ...
While pharmaceutical companies invest millions in drug development and commercialization, many overlook the critical connection between their products and patients: the pharmacy. This blind spot can ...
With penalties to pharma companies for violating the Physician Payments Sunshine Act potentially ranging into the millions of dollars, adhering to the act is a priority. But when it comes to marketing ...
LA PALMA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today ...
THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance the development of two drug ...
Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United ...
This article is authored by Tushar Gupta, COO, Jubilant Biosys Limited (CRDMO).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results